发明授权
US4749701A Aminostyryl compound, leukotriene antagonistic composition containing
the same as effective ingredients and method of antagonizing SRS by
employing the same
失效
氨基苯乙烯基化合物,含有与有效成分相同的白三烯拮抗组合物和通过使用其拮抗SRS的方法
- 专利标题: Aminostyryl compound, leukotriene antagonistic composition containing the same as effective ingredients and method of antagonizing SRS by employing the same
- 专利标题(中): 氨基苯乙烯基化合物,含有与有效成分相同的白三烯拮抗组合物和通过使用其拮抗SRS的方法
-
申请号: US941807申请日: 1986-12-15
-
公开(公告)号: US4749701A公开(公告)日: 1988-06-07
- 发明人: Yoshio Hayashi , Tomei Oguri , Masaki Shinoda , Kazuo Takahashi
- 申请人: Yoshio Hayashi , Tomei Oguri , Masaki Shinoda , Kazuo Takahashi
- 申请人地址: JPX Tokyo
- 专利权人: Mitsubishi Chemical Industries Limited
- 当前专利权人: Mitsubishi Chemical Industries Limited
- 当前专利权人地址: JPX Tokyo
- 主分类号: A61K31/195
- IPC分类号: A61K31/195 ; A61K31/19 ; A61K31/33 ; A61K31/38 ; A61K31/381 ; A61K31/415 ; A61K31/4184 ; A61K31/42 ; A61K31/423 ; A61K31/44 ; A61K31/4402 ; A61K31/4418 ; A61K31/47 ; A61K31/472 ; A61K31/495 ; A61K31/496 ; A61K31/50 ; A61K31/505 ; A61K31/517 ; A61P11/00 ; A61P37/08 ; A61P43/00 ; C07C67/00 ; C07C227/00 ; C07C229/18 ; C07C231/00 ; C07C233/07 ; C07C233/09 ; C07C233/38 ; C07D213/40 ; C07D215/12 ; C07D217/18 ; C07D235/12 ; C07D235/14 ; C07D237/08 ; C07D239/26 ; C07D239/74 ; C07D239/90 ; C07D239/91 ; C07D241/12 ; C07D263/56 ; C07D333/58 ; C07D521/00 ; C07D239/30 ; C07D239/34
摘要:
Disclosed are an aminostyryl compound represented by Formula I: ##STR1## wherein A represents a linking group having 3 to 4 chain members; B represents an unsubstituted or substituted 5 to 6-membered monocyclic type heterocyclic residue containing 1 to 2 hetero atoms, an unsubstituted or substituted condensed heterocyclic residue which contains 5 to 6-membered monocyclic type heterocycle containing 1 to 2 hetero atoms, a naphthyl group or an alkyl group having 5 to 7 carbon atoms,a composition having leukotriene antagonism which contains an aminostyryl compound represented by Formula I as the effective ingredient, and a method of antagonizing SRS based on leukotriene antagonistic activity by employing the same.
公开/授权文献
信息查询